Hogan Lovells assists EyePoint Pharmaceuticals on transformative follow-on public offering of common stock

Philadelphia, Pennsylvania, 9 February 2021 – A team from global law firm Hogan Lovells has advised EyePoint Pharmaceuticals, Inc., a pharmaceutical company committed to developing...

Press Releases

Hogan Lovells advises Novartis on Vedere Bio acquisition

New York, 10 November 2020 – International law firm Hogan Lovells is advising Novartis on its acquisition of Vedere Bio, a transaction which will add a powerful new platform for...

Press Releases

Hogan Lovells represents OptiNose in public offering

Philadelphia, 12 June 2018 – Hogan Lovells advised OptiNose, Inc., a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and...

Loading data